 |
Welcome to the PILOT™ Interactive Case Study Series 57-year-old Caucasian
female in good functional status with 2 to 4 week history of This educational activity is sponsored by The France Foundation, and is supported by an educational grant from InterMune. PILOT™ CME – Interactive Case Reviewers Kevin O. Leslie, MD click
here for bio >> Faculty Disclosure Statement It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty involved in this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a faculty member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity. Kevin O. Leslie, MD, has nothing to disclose. Steven D. Nathan, MD, has served as a consultant and speaker for and received research funding from Actelion, United Therapeutics, Gilead, and InterMune. Maria L. Padilla, MD, serves on the medical board and is a speaker for InterMune and Encysive. She is also Principal Investigator for InterMune and Actelion. Charles Strange, MD, has received grant support from Actelion, CoTherix, Encysive Pharmaceuticals, and InterMune, and has served as a consultant for InterMune. He is also on the Data Safety Monitoring Board for an IPF study with CoTherix, and has been a consultant for Encysive Pharmaceuticals concerning IPF and scleroderma. W. Richard Webb, MD, has nothing to disclose. Disclaimer The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and InterMune assume no liability for the information herein Educational Need Idiopathic pulmonary fibrosis (IPF) is a debilitating and almost uniformly fatal disease. Despite recent progress, the diagnosis and management of IPF remain distinct clinical challenges. In addition, the rapid emergence of scientific evidence has prompted a reexamination of standard clinical approaches. The aim of the PILOT™ initiative is to provide a forum for the open exchange of scientific ideas that results in the timely dissemination of emerging knowledge, facilitates clinical decision making, and improves patient outcomes. Intended Audience This educational activity is intended for pulmonologists, pathologists, radiologists, and primary care physicians treating patients with IPF. Learning Objective After reviewing the case, participants will be able to:
Accreditation Statement The France Foundation is accredited by the Accreditation Council
for Continuing Medical Education to provide continuing medical education
for physicians. The France Foundation designates this educational activity for
a maximum of 1 AMA PRA Category 1 Credit™. Physicians should
claim only credit commensurate with the extent of their participation
in the activity. This activity is eligible for CME credit from October 2007 through October 31, 2008. Method of Participation This activity, which consists of an interactive case presentation, should take approximately 1 hour to complete. The participant should complete the activity, in the order listed below:
Participants have the opportunity to comment on the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his or her views on future educational needs. To receive credit for this activity, follow the instructions provided on the online Attestation/Evaluation Form. CME credit will be valid through October 31, 2008. If you have any further questions please contact: The France Foundation |
